Cognoa Stock

Provides AI-enabled screening and care tools for early developmental and behavioral challenges.

Buy

Buy Cognoa shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Cognoa shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Cognoa develops digital diagnostic and therapeutic tools focused on early childhood development and pediatric behavioral health. It applies AI and mobile-based assessments to equip healthcare providers with insights that support faster, more equitable identification of conditions like autism.

Sector

Healthcare & Life Sciences

Founded

2011

Headquarters

Palo Alto, CA

Buy

Buy Cognoa shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Cognoa shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Investors

Major Cognoa investors

  • Morningside Group

Cognoa Valuations & Financials

Gain Insights Into Cognoa Stock Valuation & Share Prices

View real-time NPM data on Cognoa stock including daily Cognoa stock price estimates, valuation history, and historical share price information. Access Cognoa financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Cognoa pricing across six independent market signals. Looking for private company due diligence data sources on Cognoa? Get in touch to learn more.

Similar Companies

Explore companies

like Cognoa

  • Hinge Health-Logo

    Hinge Health

    Healthcare & Life Sciences

    Digital clinic for back, joint, and muscle pain.

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Weareresilience-Logo

    Resilience

    Healthcare & Life Sciences

    Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

  • Virta Health-Logo

    Virta Health

    Healthcare & Life Sciences

    Online specialty medical clinic focused on reversing type 2 diabetes.

  • Droplet Biosciences

    Healthcare & Life Sciences

    Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.

  • Elligo Health Research

    Healthcare & Life Sciences

    Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.

FAQ

Questions?

We have answers

Buy Cognoa Stock

Cognoa stock does not trade on public stock exchanges. Cognoa stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cognoa stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Cognoa Stock

Cognoa Stock does not trade on public stock exchanges. In order to sell Cognoa shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Cognoa Stock Price

Cognoa does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Cognoa share price and other valuable private market data.

Read more about secondary market private company stock prices:

Cognoa Stock Ticker Symbol

There is no ticker symbol for Cognoa stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Cognoa Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cognoa stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Cognoa Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cognoa stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Cognoa Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Cognoa IPO

Cognoa is a private company and has not had an IPO. There is currently no Cognoa IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Cognoa IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.